Cargando…
Hypoxia-Inducible Factor-2α as a Novel Target in Renal Cell Carcinoma
Hypoxia-inducible factor (HIF), an important mediator of hypoxia response, is implicated in tumorigenesis in the setting of pseudohypoxia, such as in the inactivation of von Hippel–Lindau tumor suppressor protein (pVHL), leading to development and progression of clear cell renal cell carcinoma (ccRC...
Autores principales: | Choi, Won Seok W., Boland, Julia, Lin, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033537/ https://www.ncbi.nlm.nih.gov/pubmed/33868900 http://dx.doi.org/10.15586/jkcvhl.v8i1.170 |
Ejemplares similares
-
Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma
por: Huynh, Kenneth N., et al.
Publicado: (2023) -
ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer
por: Choi, WonSeok William, et al.
Publicado: (2022) -
Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
por: Xiong, Anji, et al.
Publicado: (2017) -
Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma
por: Fukumoto, Wataru, et al.
Publicado: (2023) -
The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis
por: Lin, Xunyi, et al.
Publicado: (2023)